
AXELEROS Preclinical Development
AXELEROS Preclinical Development streamlines the preclinical development process for pharmaceutical, medical devices, chemical, and advanced technologies for our European-funded health clients. Leveraging our deep regulatory affairs and scientific expertise, we provide efficient and tailored expert partnership solutions, enabling biotechs, SMEs, and researchers to accelerate the journey of their innovative therapies to market

Expert Regulatory Consultants
Bringing over 20 years of experience in Preclinical Development and Global Regulatory Affairs, we are driven by a passion for excellence. Our journey is marked by significant milestones and achievements, reflecting our commitment to providing unparalleled regulatory and scientific expertise. Our team is dedicated to facilitating the success of our clients by ensuring safety and efficacy through regulatory compliance while fostering health access innovation.
Why Choose Us?
Regulatory
Expertise
Proven track record in representing clients before regulatory health agencies and enabling first-time human trials.
EU Public Affairs
Expertise in European health sector regulations, funding and compliance
Strategic
Guidance
Tailored solutions to optimize regulatory pathway while reducing development costs
Accelerated Success
Streamlined regulatory strategies to help biotech companies bring treatments to market faster
Our Services
At AXELEROS Preclinical Development, we offer a comprehensive range of preclinical expert services designed to support our clients in achieving their regulatory and scientific drug / vaccine/ medical device/ chemical development objectives. Our expert services include preclinical regulatory strategy and study execution, nonclinical regulatory representation, and expertise and collaboration in the EU public affairs health sector.
We are dedicated to delivering exceptional value and expertise to ensure our clients' success.
​
Accelerate your biotech journey from "lab to market" with AXELEROS Preclinical Development Today!